April 6, 2023 12:25 PM EDT
Manufacturing

Man­u­fac­tur­ing roundup: In­vest­ment firm buys Pfiz­er fa­cil­i­ty in Aus­tralia; Cam­brex opens new fa­cil­i­ty in Bel­gium

Tyler Patchen

News Reporter

Pri­vate in­vest­ment firm Bridgewest Group has closed its ac­qui­si­tion of a for­mer Pfiz­er man­u­fac­tur­ing site out­side of Perth, Aus­tralia.

The new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times